The Bioquell PLC Board

Ian Johnson

Executive Chairman
Ian has spent his business career in life science and was founder and CEO of Biotrace International Plc, which was a listed company until its sale to 3M in December 2006. Ian is currently non-executive chairman of Cyprotex PLC and Biofortuna Ltd and was until their sale in 2015, chairman of Celsis Group and Lumora Ltd.  He has served on the boards of various public and private companies in strategic consultancy and business development capacities including: Evans Analytical Group, MyCelx Technologies Corporation and AOI Medical Inc., each AIM traded companies.

Ian studied at Cardiff University obtaining a B.Sc. and M.Sc. in Microbiology. He is a chartered biologist, a member of the Royal Society of Biology and the Institute of Directors.

Michael Roller ACA

Group Finance Director
Joined the Board on 19 March 2014. He has previously been Finance Director of a number of quoted companies, most recently Corin Group plc, has significant experience within the Life Sciences sector and is a non-executive director of Filtronic plc. He has also held a number of other senior finance roles in a broad range of listed and private companies. He qualified as an accountant with KPMG.

Jay LeCoque

Commercial Director
Joined the Board on 24th August 2016. Jay was CEO of Celsis International Ltd (formerly Celsis International plc) from 2000 to 2015. He joined Celsis during its start-up days in 1995 as a Director of Global Business Development.

LeCoque previously worked for Baxter Healthcare (NYSE) and AptarGroup (NYSE) in various global sales and marketing roles. LeCoque received his MBA from Northwestern University’s Kellogg Graduate School of Management in 1991 and his BS from Miami University in Oxford, Ohio in 1985.

Simon Constantine, ACA*

Non-executive Director
Joined the Board in November 1999. Previously he held a number of financial and operational positions at Board level within Life Sciences International PLC. He is also Chairman of Capstone Foster Care Ltd and Reinnervate Ltd.


Christopher Mills**

Non-executive Director
Joined the Board in December 2012. He is Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust PLC, a director of Oryx International Growth Fund Ltd and is the Chief Investment Officer and a member of Harwood Capital LLP.

Sir Ian Carruthers, OBE*

Non-executive Director
Joined the Board in August 2010. He is former Chief Executive of the NHS South of England and has extensive experience of the UK and international healthcare systems. He is a Non-executive Director of Partnerships in Care, Chancellor of the University of West of England and Chair of Healthcare UK.


*   Member of the Audit, Remuneration and Nominations Committees.
**  Member of the Remuneration Committee.